In South Africa, Success Against H.I.V. Offers Hope
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus […]
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus […]
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus […]
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus […]
A former Africa correspondent, who covered the height of the AIDS epidemic there 15 years ago, finds lessons in the remarkable progress against that virus […]
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Two shots of the vaccine reduced the risk of hospitalization from the fast-spreading variant by 85 percent, a clinical trial found.
Data from a real-world study South Africa has indicated that the Omicron variant of COVID-19 is 29% less likely to cause hospitalisation among infected adults […]
Scientists in a cutting-edge laboratory do part of the work. Local health workers on foot do the rest.
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen […]
By MIKE MAGEE Texas Governor Greg Abbott has been on a tear lately, and his central theme appears to be “revanchism.” Faced with declining demographics, […]
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
Researchers ended a large trial in South Africa after finding that an experimental vaccine offered little protection.
Health experts say that boosters are likely to be needed eventually and that more data should be available in the next several weeks.
Twenty years ago in South Africa people were dying unable to access expensive antiretrovirals. The creation of the Global Fund was gamechanging In 2001, at […]
Efforts in Africa and elsewhere hit by decision not to export AstraZeneca jab from India until end of year Coronavirus – latest updates See all […]
Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a […]
Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a […]
Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage […]
Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major […]
Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage […]
Mientras las regiones con más recursos compran vacunas, otras podrían convertirse en caldo de cultivo de mutaciones que podrían hacer que las vacunas en general […]
Rich countries are buying up coronavirus vaccines, leaving poorer regions vulnerable — and as potential breeding grounds for variants, like one found in South Africa, […]
Rich countries are cornering the market on coronavirus vaccines, leaving poorer regions as potential breeding grounds for variants, like one found in South Africa, that […]
Shots: REGEN-COV neutralizes the SARS-CoV-2 B.1.1.7 variants, identified in the UK & SA. The data was included in a bioRxiv paper and submitted for peer-reviewed […]
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
Global inequality is shaping which countries get vaccines first. In South Africa, people’s best chance for vaccines anytime soon is to join an experimental trial.
The system that built a coronavirus vaccine in record time relies on robust intellectual property protections.
The system that built a coronavirus vaccine in record time relies on robust intellectual property protections.
Otherwise, there won’t be enough shots to go around, even in rich countries.
Shots: Alvotech and Cipla entered an exclusive partnership to provide patients with better access to high quality and cost-effective biosimilar medicines in South Africa Alvotech […]
Copyright © 2024 | WordPress Theme by MH Themes